Amylyx Pharmaceuticals Inc (AMLX)

08:29 AM

Goldman Sachs reiterates Neutral on Amylyx stock, target unchanged amid PBH market uncertainties - Investing.com

08:29 AM

Nov 20, 2024

Amylyx Pharmaceuticals upgraded to Outperform at Baird, shares rise - MSN

Nov 20, 2024

Nov 19, 2024

Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating Upgraded by Baird R W - MarketBeat

Nov 19, 2024

Nov 19, 2024

Baird Upgrades Amylyx Pharmaceuticals (AMLX) - MSN

Nov 19, 2024

Nov 18, 2024

Amylyx Pharmaceuticals upgraded to Outperform at Baird, shares rise (NASDAQ:AMLX) - Seeking Alpha

Nov 18, 2024

Nov 18, 2024

Amylyx Pharmaceuticals (NASDAQ:AMLX) Upgraded by Robert W. Baird to Outperform Rating - MarketBeat

Nov 18, 2024

Nov 15, 2024

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Short Interest Update - MarketBeat

Nov 15, 2024

Nov 11, 2024

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

Nov 09, 2024

Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023) - Yahoo Finance

Nov 09, 2024

Nov 08, 2024

Amylyx Pharmaceuticals (NASDAQ:AMLX) Given New $12.00 Price Target at HC Wainwright - MarketBeat

Nov 08, 2024

Nov 08, 2024

Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Nov 08, 2024

Nov 08, 2024

Amylyx Pharmaceuticals Q3 2024 Financial Highlights - TipRanks

Nov 08, 2024

Nov 07, 2024

Amylyx Pharmaceuticals Inc. (AMLX) Quarterly 10-Q Report - Quartz

Nov 07, 2024

Nov 07, 2024

Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024

Nov 07, 2024

Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results - The Bakersfield Californian

Nov 07, 2024

Nov 07, 2024

Amylyx Reports Mixed Q3: Positive Trial Data Despite $72.7M Loss, Cash Runway Into 2026 | AMLX Stock News - StockTitan

Nov 07, 2024

Nov 05, 2024

Amylyx Pharmaceuticals (AMLX) to Release Earnings on Thursday - MarketBeat

Nov 05, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Amylyx Pharmaceutica - GuruFocus.com

Nov 05, 2024

Nov 04, 2024

There's No Escaping Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Muted Revenues Despite A 81% Share Price Rise - Simply Wall St

Nov 04, 2024

Nov 04, 2024

Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 - StockTitan

Nov 04, 2024

Nov 03, 2024

abrdn plc Buys 1,853,995 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat

Nov 03, 2024

Nov 01, 2024

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Nov 01, 2024

Oct 30, 2024

Levi & Korsinsky Reminds Amylyx Investors of the Pending Class A - GuruFocus.com

Oct 30, 2024

Oct 28, 2024

Short Interest in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Declines By 21.1% - MarketBeat

Oct 28, 2024

Oct 25, 2024

Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals Inc - Yahoo Finance

Oct 25, 2024

Oct 25, 2024

Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharma - GuruFocus.com

Oct 25, 2024

Oct 24, 2024

Amylyx upgraded to buy by BofA on hypoglycemia drug potential - MSN

Oct 24, 2024

Oct 23, 2024

BofA upgrades Amylyx stock to Buy rating By Investing.com - Investing.com Australia

Oct 23, 2024

Oct 23, 2024

BofA upgrades Amylyx stock to Buy rating - Investing.com

Oct 23, 2024

Oct 23, 2024

Amylyx Pharmaceuticals (NASDAQ:AMLX) Upgraded to Buy by Bank of America - MarketBeat

Oct 23, 2024

Oct 22, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Acti - GuruFocus.com

Oct 22, 2024

Oct 21, 2024

October 2024's US Penny Stocks Poised For Growth - Simply Wall St

Oct 21, 2024

Oct 19, 2024

Amylyx Pharmaceuticals reports results from pancreatic disease treatment trial - MSN

Oct 19, 2024

Oct 19, 2024

Amylyx Pharmaceuticals (AMLX): Leading Nano Cap in Neurodegenerative Disease Treatments - Insider Monkey

Oct 19, 2024

Oct 18, 2024

Why Amylyx Pharmaceuticals Stock Was So Healthy This Week - MSN

Oct 18, 2024

Oct 18, 2024

Amylyx shares reiterate Buy rating on trial data - Investing.com

Oct 18, 2024

Oct 18, 2024

Amylyx shares reiterate Buy rating on trial data By Investing.com - Investing.com UK

Oct 18, 2024

Oct 18, 2024

Amylyx Pharmaceuticals (NASDAQ:AMLX) Receives "Buy" Rating from HC Wainwright - MarketBeat

Oct 18, 2024

Oct 18, 2024

H.C. Wainwright maintains Buy rating on Amylyx shares on trial data - Investing.com

Oct 18, 2024

Oct 18, 2024

H.C. Wainwright maintains Buy rating on Amylyx shares on trial data By Investing.com - Investing.com UK

Oct 18, 2024

Oct 18, 2024

Amylyx’s AMX0035 shows promise in Phase II Wolfram syndrome trial - Clinical Trials Arena

Oct 18, 2024

Oct 18, 2024

PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug - Yahoo Finance

Oct 18, 2024

Oct 18, 2024

Leerink maintains Market Perform rating on Amylyx stock on new data - Investing.com

Oct 18, 2024

Oct 18, 2024

Leerink maintains Market Perform rating on Amylyx stock on new data By Investing.com - Investing.com South Africa

Oct 18, 2024

Oct 17, 2024

Amylyx reports positive trial results for Wolfram syndrome treatment - Investing.com India

Oct 17, 2024

Oct 17, 2024

Amylyx reports positive trial results for Wolfram syndrome treatment By Investing.com - Investing.com South Africa

Oct 17, 2024

Oct 17, 2024

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome - StockTitan

Oct 17, 2024

Oct 15, 2024

Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024 - BioSpace

Oct 15, 2024